Literature DB >> 8410128

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study.

L Ovesen1, L Allingstrup, J Hannibal, E L Mortensen, O P Hansen.   

Abstract

PURPOSE: This study examined the effect of frequent nutritional counseling on oral intake, body weight, response rate, survival, and quality of life in patients with cancer of the lung (small-cell), ovary, or breast undergoing cyclic chemotherapy. PATIENTS AND METHODS: Of 105 assessable patients, 57 were randomized to receive nutritional counseling, and 48 to receive no nutritional counseling and consumption of an ad lib oral intake. The intervention group was counseled to achieve a daily energy and protein intake according to recommended dietary allowances. Counseling was standardized and performed by a trained dietitian, and took place twice monthly during a 5-month period from start of chemotherapy.
RESULTS: Dietary counseling increased daily energy intake by approximately 1 MJ and protein intake by 10 g over the entire study period. There was no change in the control group. Counseling led to an insignificant increase in body weight, but triceps skinfold measurement increased significantly after 5 months. Response rate and overall survival did not differ between the groups. Quality of life measured by the Quality-of-Life index (QL-index) increased significantly in both groups, but did not differ between groups.
CONCLUSION: No clinical benefit could be demonstrated despite long-term and continuous improved food intake in cancer patients with solid tumors undergoing aggressive chemotherapy.

Entities:  

Mesh:

Year:  1993        PMID: 8410128     DOI: 10.1200/JCO.1993.11.10.2043

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  53 in total

Review 1.  The cancer anorexia/weight loss syndrome: therapeutic challenges.

Authors:  Karin F Giordano; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

2.  Nutritional therapy for cancer cachexia.

Authors:  R F Grimble
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 3.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

4.  Trials in palliative care.

Authors:  G Rinck; J Kleijnen; T G Van den Bos; H J de Haes; E Schadé; C H Veenhof
Journal:  BMJ       Date:  1995-03-04

Review 5.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 6.  Treatment of non-pain-related symptoms.

Authors:  Charles F von Gunten; Ellin Gafford
Journal:  Cancer J       Date:  2013 Sep-Oct       Impact factor: 3.360

7.  Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Authors:  K C H Fearon; M F Von Meyenfeldt; A G W Moses; R Van Geenen; A Roy; D J Gouma; A Giacosa; A Van Gossum; J Bauer; M D Barber; N K Aaronson; A C Voss; M J Tisdale
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 8.  Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2021-07-26       Impact factor: 3.603

9.  Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.

Authors:  Ian D Schnadig; Erik K Fromme; Charles L Loprinzi; Jeff A Sloan; Motomi Mori; Hong Li; Tomasz M Beer
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 10.  A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer.

Authors:  Martin R Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2009-07-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.